How Quantum Computing Is Making Drug Discovery Faster

In this episode, Lucas and Luna explore how quantum computing is accelerating the early stages of drug discovery. They focus on a concrete example: simulating molecular interactions for a potential cancer therapy, a process that would take classical computers thousands of years. Lucas explains how quantum algorithms from companies like IonQ and D-Wave are being tested by pharmaceutical giants like Pfizer and Roche. They discuss the current limitations—noise, error correction, qubit count—and why hybrid classical-quantum models are the near-term reality. Luna asks whether the hype matches the timeline, and Lucas digs into the numbers: the pharmaceutical industry spends $2.6 billion on average to bring a single drug to market, and quantum simulations could cut preclinical costs by 30 percent. The episode gives listeners a grounded sense of where quantum computing actually stands in drug R&D today, without overpromising. #QuantumComputing #DrugDiscovery #Pharmaceuticals #IonQ #DWave #Pfizer #Roche #MolecularSimulation #HybridQuantum #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #TechPodcast #DrugDevelopment #QuantumAlgorithms #QuantumChemistry #ComputationalBiology #Innovation Keep every episode free: buymeacoffee.com/fexingo